Oregon Public Employees Retirement Fund Increases Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Oregon Public Employees Retirement Fund boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.5% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 36,482 shares of the company’s stock after buying an additional 176 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in GE HealthCare Technologies were worth $2,843,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. Little House Capital LLC lifted its stake in shares of GE HealthCare Technologies by 1.8% in the 2nd quarter. Little House Capital LLC now owns 8,074 shares of the company’s stock valued at $629,000 after purchasing an additional 141 shares during the period. Rhumbline Advisers lifted its position in GE HealthCare Technologies by 4.5% during the second quarter. Rhumbline Advisers now owns 802,154 shares of the company’s stock valued at $62,504,000 after buying an additional 34,307 shares during the period. CIBC Asset Management Inc boosted its holdings in shares of GE HealthCare Technologies by 1.4% during the 2nd quarter. CIBC Asset Management Inc now owns 130,235 shares of the company’s stock valued at $10,148,000 after buying an additional 1,747 shares in the last quarter. Financial Counselors Inc. grew its position in shares of GE HealthCare Technologies by 2.7% in the 2nd quarter. Financial Counselors Inc. now owns 10,877 shares of the company’s stock worth $848,000 after buying an additional 286 shares during the period. Finally, Natixis Advisors LLC lifted its position in GE HealthCare Technologies by 6.1% during the 2nd quarter. Natixis Advisors LLC now owns 278,071 shares of the company’s stock valued at $21,668,000 after acquiring an additional 16,044 shares during the period. 82.06% of the stock is owned by institutional investors.

Analyst Ratings Changes

GEHC has been the topic of a number of recent research reports. The Goldman Sachs Group initiated coverage on shares of GE HealthCare Technologies in a report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price objective on the stock. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Finally, Stifel Nicolaus began coverage on GE HealthCare Technologies in a research note on Tuesday, August 6th. They set a “buy” rating and a $100.00 price objective for the company. Five investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $95.00.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at approximately $1,414,377.02. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.27% of the stock is owned by company insiders.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $87.29 on Friday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. The firm has a market cap of $39.84 billion, a price-to-earnings ratio of 25.52, a price-to-earnings-growth ratio of 3.17 and a beta of 1.17. The business has a 50-day simple moving average of $81.95 and a two-hundred day simple moving average of $83.53. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The firm had revenue of $4.84 billion during the quarter, compared to analysts’ expectations of $4.88 billion. During the same period in the previous year, the company earned $0.92 earnings per share. The firm’s quarterly revenue was up .5% on a year-over-year basis. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were issued a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. The ex-dividend date was Friday, July 19th. GE HealthCare Technologies’s payout ratio is currently 3.51%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.